Position in GILD
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$4,733,201
-$593,659 QoQ
Shares Held
37,464
-2.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#593
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Simmons Bank holds $67,934,657 across 11 Drug Manufacturers - General names. GILD ranks #6 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
51,844 | $13,046,023 | |
| 2 | LLY |
ELI LILLY & Co
|
10,864 | $13,030,606 | |
| 3 | AMGN |
Amgen Inc
|
26,161 | $9,473,419 | |
| 4 | MRK |
Merck & Co., Inc.
|
70,419 | $9,048,841 | |
| 5 | JNJ |
Johnson & Johnson
|
35,136 | $8,923,488 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
37,464 | $4,733,201 | |
| 7 | PFE |
Pfizer Inc
|
125,117 | $3,012,817 | |
| 8 | GSK |
GSK plc
|
57,449 | $3,011,475 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,733,201 | 37,464 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $5,326,860 | 38,221 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $4,688,790 | 38,201 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $4,123,539 | 37,149 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $4,275,479 | 38,563 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $4,313,364 | 38,495 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $3,700,157 | 40,058 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $3,325,429 | 39,664 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $2,952,287 | 43,030 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $3,117,959 | 42,566 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,806,173 | 46,984 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $3,566,769 | 47,595 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $3,616,663 | 46,927 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $3,856,362 | 46,479 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $3,958,886 | 46,114 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $2,846,560 | 46,143 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $2,785,961 | 45,073 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $2,494,640 | 41,962 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $3,034,806 | 41,796 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $3,056,355 | 43,756 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $2,989,487 | 43,414 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $2,910,482 | 45,033 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $2,677,803 | 45,963 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $2,854,418 | 45,172 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $4,361,650 | 56,689 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $4,066,419 | 54,393 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||